Currently serves as the Chief of Molecular Cancer Medicine Service at Memorial Sloan Kettering
Serves on Board of Qiagen and C4 Therapeutics SAB
Previously served on SAB of Loxo Oncology
Received his M.D from The Johns Hopkins School of Medicine and was trained in hematology-oncology at Dana Farber
